The severe epilepsy syndromes of infancy: A population-based study

Katherine B Howell1,2,3, Jeremy L Freeman1,3, Mark T Mackay2,3

  • 1Department of Neurology, Royal Children's Hospital, Melbourne, Vic, Australia.

Epilepsia
|January 21, 2021
PubMed

Insights

Severe infantile epilepsies are often diagnosed as specific syndromes, guiding early treatment and prognosis. West syndrome and West syndrome-like epilepsy are most common, with significant developmental delays and mortality in affected infants.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Developmental Neuroscience

Background:

  • Severe epilepsies in infancy present diagnostic and therapeutic challenges.
  • Accurate classification of epilepsy syndromes is crucial for understanding disease trajectory.

Purpose of the Study:

  • To investigate the incidence, etiologies, and outcomes of severe epilepsy syndromes in infants.
  • To assess the utility of syndrome diagnosis in early infantile epilepsies.

Main Methods:

  • Population-based cohort study in Victoria, Australia, of infants with epilepsy onset before 18 months.
  • Diagnosis of International League Against Epilepsy epilepsy syndromes by two epileptologists using clinical data, videos, and EEGs.
  • Determination of incidence, etiologies, and 2-year outcomes.

Main Results:

  • 64% of infants met criteria for epilepsy syndromes, with 14% having variants.
  • West syndrome and West syndrome-like epilepsy were most common (32.7/100,000 live births/year).
  • Structural etiologies were frequent in some syndromes, while genetic disorders predominated in others; 16% mortality and 42% severe-profound developmental delay by age 2.

Conclusions:

  • A significant majority of severe infantile epilepsies can be classified into syndromes or variant syndromes.
  • Syndrome diagnosis at presentation is clinically valuable for guiding etiological investigations, treatment, and prognosis, even with advanced diagnostics.
  • Early identification of epilepsy syndromes aids in predicting outcomes and tailoring interventions for infants.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
896
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
955